Vilatin-M 50/500 Tablet

Description

Vilatin-M 50/500 Tablet is a combination of two medications that work together to control high blood sugar levels in individuals with type 2 diabetes mellitus. By regulating blood sugar, it helps prevent severe complications associated with diabetes, such as kidney damage and blindness, and may also reduce the risk of heart attacks or strokes.

Salt Composition
Metformin (500mg) + Vildagliptin (50mg)

How to Use
Take Vilatin-M 50/500 Tablet as prescribed by your doctor. Swallow the tablet whole, without chewing, crushing, or breaking it. It is recommended to take this medicine with food to help prevent an upset stomach.

Uses/Benefits
Vilatin-M 50/500 Tablet is used to treat type 2 diabetes mellitus. The combination of metformin and vildagliptin works in different ways to lower blood glucose levels. Maintaining controlled blood sugar levels reduces the risk of severe diabetes complications, such as kidney damage, eye problems, nerve issues, and limb loss. It also helps lower the risk of heart disease and stroke. Regular use, alongside a healthy diet and exercise, contributes to long-term health and wellness.

Side Effects
Most side effects are mild and may go away as your body adjusts to the medication. Common side effects include:

• Hypoglycemia (low blood glucose)
• Trembling
• Headache
• Dizziness
• Nausea
• Weakness
• Gastro-esophageal reflux disease
• Increased sweating
• Decreased appetite

Consult your doctor if any side effects persist or cause concern.

Restrictions

• Alcohol: Unsafe to consume with Vilatin-M 50/500 Tablet.
• Pregnancy: Consult your doctor before use, as animal studies suggest harmful effects on the developing baby.
• Breastfeeding: Consult your doctor, as the drug may pass into breast milk and potentially harm the baby.
• Driving: Exercise caution when driving, as blood sugar imbalances can impair your ability to drive safely.
• Kidney: Use with caution in patients with kidney disease. Dose adjustments may be necessary.
• Liver: Unsafe for use in patients with liver disease.

Marketed By
Ajanta Pharma Ltd